CLINICAL_TRIALS
trial_result
· 2019-06-18
Clinical Trial Update: Efficacy and Safety of SPARC0921 in Subjects With Spasticity [Phase 3]
Summary
Phase 3 trial results for SPARC0921 in spasticity have been completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2019-06-18